Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-07-17
1996-08-20
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
055479910
ABSTRACT:
The present invention is directed to a class of 4,6-disubstituted tryptophan derivatives, 4,6-disubstituted kynurenines, their use as NMDA antagonists and to pharmaceutical compositions containing these compounds.
REFERENCES:
patent: 3445479 (1969-05-01), Hydorn
patent: 4140697 (1979-02-01), Batcho et al.
The Journal of Neuroscience, Sep. 1990, 10(9):2965-297: Cerebral Synthesis and Release of Kynurenic Acid: an Endogenous Antagonist of Excitatory Amino Acid Receptors.
Society For Neuroscience Abstracts, vol. 17, 1991; 315.3; Systemic Loading with Kynurenine and Probenecid Markedly increases Striatal Kynurenic Acid Levels as Measured by In Vivo Microialysis, Miller, et al.
Chemical Abstracts 112(7):52836c; Uptake of kynurenine into rat brain slices, Speciale, et al. (1990).
Chemical Abstracts 76(25):150339a:Enzymic studies of the biosnythesis of 5-hydroxyl-L-kynurenine in the rat small intestine, Konishi (1972).
Chemical Abstracts 75 (3): 17141t; Pyrrole ring cleavaging enzyme of 5-hydroxytryptophan, konishi, et al. (1971).
Chemical Abstracts 69(9):33829e; Formation of 5-hydroxy-L-kynurenine from L-kynurenine by hen liver microsomes; Kido, et al. (1968).
Chemical Abstracts 72(3)9673r; Influence of androgens on tryptophan metabolism in man, McGinty, et al. (1970).
Chemical Abstracts 74(21):107987g; Gas chromatographic analysis of tryptophan metabolites, Noguchi et al. (1971).
Chemical Abstracts 72(21):107236v; 5-Hydroxykynurenine decarboxylase in rat intestine, Noguchi, et al (1970).
Chemical Abstracts 67(21):96860n; (1967) Metabolism of tryptophan, Griggio et al.
Chemical Abstracts 111 (24):219114j; Sunscreens and skin-lightening cosmetics containing kynurenines; Narutomi, et al. (1989).
Chemical Abstracts 92(5):36767u; The Mechanism of Kynurenine hydrolysis catalyzed by kynureninase, Tanizawa, et al. (1980).
Chemical Abstracts 97(15):125986K; Halogenoanthranyloylalanines as sweeteners; Tanabe (1982).
Chemical Abstracts 93(25):239866u; An intensely sweet analog of kynurenine; Kawashima, et al. (1980).
Chemical Abstracts, 109:48451u (1988).
Chemical Abstracts, 106:207831z (1987).
Chemical Abstracts, 95:55548b (1981).
Chemical Abstract, 106:78724r (1987).
Chemical Abstracts, 72:30438c (1970).
Chemical Abstracts, 83:131913m (1975).
Chemical Abstracts, 83:114922w (1975).
Chemical Abstracts, 96: 11515w (1982).
Beilsteins Handbuch Org. Chem. Syst. EII Nr. 3436, p. 420 (1951).
Beilsteins Handbuch, Org. Chem. EIII/IV Syst. Nr. 3436, p. 6,809 and 6817 (1980).
Kynurenine metabolites of tryptophan: Implications for neurologic diseases; Freese, et al. 40 Neurology 691-695; Apr. 1990.
10-Microbia Biochem, vol. 112, 1990, Abstract No. 135860g.
McDonald Ian A.
Palfreyman Michael G.
Salituro Francesco G.
Schwarcz Robert
Dixon J. Michael
Merrell Pharmaceuticals Inc.
Springer David B.
LandOfFree
NMDA antagonism method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NMDA antagonism method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NMDA antagonism method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2331090